The goals of our Neuroscience and Neuroimaging Laboratory in Child and Adolescent Psychiatry are to study brain development and functioning in children, along with the influence of specific genetic factors on development. We aim at better understanding how genetic and brain alterations contribute to the emergence of cognitive or behavioral difficulties or psychiatric disorders during the course of development. Our research focuses on individuals who have genetic, neuropsychiatric or neurodevelopmental disorders, which result in behavior, learning or emotional regulation difficulties. A collaborative multidisciplinary approach that includes genetic, structural and functional neuroimaging and cognitive neuroscience has the following goals: a better definition of neurogenetic syndromes and conditions studied; identify markers of cognitive impairments; identify risk factors for psychiatric diseases and symptoms; use specific neurogenetic conditions as a homogeneous genetic model to better understand interactions between genes, brain, behavior and environmental factors in the etiopathogeny of neuropsychiatric diseases.
Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome.
Correction to: Next generation Europe: a recovery plan for children, adolescents and their families : For the time after the pandemic, we need a vision and investments for the future.
Age-Related Improvements in Executive Functions and Focal Attention in 22q11.2 Deletion Syndrome Vary Across Domain and Task.
Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
Département de psychiatrie